Le Lézard
Classified in: Health
Subjects: SVY, POL, MAT

Daily cannabis users less likely to consider heavy tobacco use dangerous


NEW YORK, Aug. 10, 2022 /PRNewswire/ -- A growing number of Americans are using cannabis as it becomes legalized for recreational adult use in a rapidly increasing number of U.S. states. Questions abound about what impact legalization will have on adult and youth health.

A new study led by Dr. Renee Goodwin, Professor at the CUNY Graduate School of Public Health and Health Policy (CUNY SPH), shows that increased cigarette use is one possibility. While cigarette use has been declining for decades in the U.S., a new study finds that adults who use cannabis daily do not perceive smoking a pack a day as being as harmful as those who do not use cannabis in the U.S. In the context of recent findings that perception of risk plays a key role in predicting substance use, and that perception of risk associated with cannabis use has declined steadily along with legalization, these findings were somewhat of a surprise.

The researchers used data from adults age 18 and older in the 2020 National Survey on Drug Use and Health, a representative survey of U.S. individuals. Participants' responses to a question asking how much people risk harming themselves physically and in other ways by smoking one or more packs of cigarettes per day were compared between those who use cannabis daily and those who did not use cannabis in the past year. Sixty-two percent of adults who use cannabis daily perceived pack a day cigarette use to be of "great" risk to health, compared with 73% of those who did not use cannabis in the past year.

"Tobacco control has done a tremendous job in public education on the physical health risks associated with tobacco use, and cigarette smoking in particular, over the past several decades," says Goodwin, also an adjunct professor at Columbia Mailman School of Public Health. Her prior work shows that cigarette use, however, is much more common among those who use cannabis and findings suggesting that cannabis legalization may lead to increases in cannabis use and cannabis-cigarette co-use among adults. 

"We wondered why that might be," Goodwin says. "Our findings suggest that diminished risk perception of pack a day cigarette use might be one contributing factor."

Dr. Goodwin discussed her work, and in particular that of Canadian colleagues, at a recent public hearing for a law that would ban cannabis packaging that appeals to children in New York's Suffolk County. Findings from recent studies in Canada, where cannabis is legal on a federal level, show increases in adult cannabis use but as of the most recent study in 2022, no significant increases in cannabis use among adolescents.

Renee D Goodwin, Meng Xi Sun, Keely Cheslack-Postava, Everything old is new again: Creating and maintaining a population-level 'shared reality' of health risks associated with cigarette use toward both reducing the prevalence and eliminating disparities in cigarette use among all Americans, Nicotine & Tobacco Research, 2022;, ntac177, https://doi.org/10.1093/ntr/ntac177

For media inquiries, contact:
Ariana Costakes
Communications Editorial Manager
[email protected]

SOURCE CUNY SPH


These press releases may also interest you

at 02:10
Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883), a pioneering company developing innovative drugs for the treatment of rare genetic diseases, utilizing its proprietary CRISPR-based epigenome editing technology CRISPR-GNDM®, posted the...

at 02:00
Exams can be daunting for students and parents, but with the right approach it can become a rewarding and manageable experience. Expert private tutors can support academic study and exam-readiness while promoting students' mental health with...

at 02:00
As part of its Global Science Summit, the Novo Nordisk Foundation issues an international open call for research projects to catalyse science-based solutions to key global challenges. The programme expects to hand out up to eight grants with a total...

at 02:00
"Nando", a leading Lithuanian-owned biotechnology company known for its groundbreaking work in developing microbiological products for agriculture, that helped to save up to 50M on fertilisers, announces a significant bolstering of its...

at 01:27
GC Genome Corporation, a leading diagnostics company, today announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology (ASCO) Annual...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced that the Company will hold a conference call on Tuesday, May 14, 2024, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business...



News published on and distributed by: